P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Track: SCLC, Mesothelioma, Thymoma.
Identifieur interne : 001988 ( Main/Exploration ); précédent : 001987; suivant : 001989P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Track: SCLC, Mesothelioma, Thymoma.
Auteurs : Giorgio V. Scagliotti ; Rabab Gaafar ; Anna Nowak ; Nicholas J. Vogelzang ; Ute Von Wangenheim ; Nassim Morsli ; Derek Velema ; Sanjay PopatSource :
- Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [ 1556-1380 ] ; 2016.
DOI: 10.1016/j.jtho.2016.08.075
PubMed: 27676538
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001808
- to stream PubMed, to step Curation: 001785
- to stream PubMed, to step Checkpoint: 001785
- to stream Ncbi, to step Merge: 003C17
- to stream Ncbi, to step Curation: 003C17
- to stream Ncbi, to step Checkpoint: 003C17
- to stream Main, to step Merge: 001984
- to stream Main, to step Curation: 001988
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Track: SCLC, Mesothelioma, Thymoma.</title><author><name sortKey="Scagliotti, Giorgio V" sort="Scagliotti, Giorgio V" uniqKey="Scagliotti G" first="Giorgio V" last="Scagliotti">Giorgio V. Scagliotti</name><affiliation><nlm:affiliation>Department of Oncology, University of Turin, Torino/ITALY.</nlm:affiliation><wicri:noCountry code="subField">Torino/ITALY</wicri:noCountry></affiliation></author><author><name sortKey="Gaafar, Rabab" sort="Gaafar, Rabab" uniqKey="Gaafar R" first="Rabab" last="Gaafar">Rabab Gaafar</name><affiliation><nlm:affiliation>National Cancer Institute, Cairo University, Cairo/EGYPT.</nlm:affiliation><wicri:noCountry code="subField">Cairo/EGYPT</wicri:noCountry></affiliation></author><author><name sortKey="Nowak, Anna" sort="Nowak, Anna" uniqKey="Nowak A" first="Anna" last="Nowak">Anna Nowak</name><affiliation><nlm:affiliation>School of Medicine And Pharmacology Qeii, Medical Centre Unit, University of Western Australia, Crawley/WA/AUSTRALIA.</nlm:affiliation><wicri:noCountry code="subField">Crawley/WA/AUSTRALIA</wicri:noCountry></affiliation></author><author><name sortKey="Vogelzang, Nicholas J" sort="Vogelzang, Nicholas J" uniqKey="Vogelzang N" first="Nicholas J" last="Vogelzang">Nicholas J. Vogelzang</name><affiliation><nlm:affiliation>US Oncology Comprehensive Cancer Centers of Nevada, Las Vegas/NV/UNITED STATES OF AMERICA.</nlm:affiliation><wicri:noCountry code="subField">Las Vegas/NV/UNITED STATES OF AMERICA</wicri:noCountry></affiliation></author><author><name sortKey="Von Wangenheim, Ute" sort="Von Wangenheim, Ute" uniqKey="Von Wangenheim U" first="Ute" last="Von Wangenheim">Ute Von Wangenheim</name><affiliation><nlm:affiliation>Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/GERMANY.</nlm:affiliation><wicri:noCountry code="subField">Biberach/GERMANY</wicri:noCountry></affiliation></author><author><name sortKey="Morsli, Nassim" sort="Morsli, Nassim" uniqKey="Morsli N" first="Nassim" last="Morsli">Nassim Morsli</name><affiliation><nlm:affiliation>Boehringer Ingelheim France S.A.S., Paris/FRANCE.</nlm:affiliation><wicri:noCountry code="subField">Paris/FRANCE</wicri:noCountry></affiliation></author><author><name sortKey="Velema, Derek" sort="Velema, Derek" uniqKey="Velema D" first="Derek" last="Velema">Derek Velema</name><affiliation><nlm:affiliation>Boehringer Ingelheim (Canada) Ltd./Ltée, Burlington/ON/CANADA.</nlm:affiliation><wicri:noCountry code="subField">Burlington/ON/CANADA</wicri:noCountry></affiliation></author><author><name sortKey="Popat, Sanjay" sort="Popat, Sanjay" uniqKey="Popat S" first="Sanjay" last="Popat">Sanjay Popat</name><affiliation><nlm:affiliation>Royal Marsden Hospital NHS Foundation Trust, London and Surrey/UNITED KINGDOM.</nlm:affiliation><wicri:noCountry code="subField">London and Surrey/UNITED KINGDOM</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27676538</idno><idno type="pmid">27676538</idno><idno type="doi">10.1016/j.jtho.2016.08.075</idno><idno type="wicri:Area/PubMed/Corpus">001808</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001808</idno><idno type="wicri:Area/PubMed/Curation">001785</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001785</idno><idno type="wicri:Area/PubMed/Checkpoint">001785</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001785</idno><idno type="wicri:Area/Ncbi/Merge">003C17</idno><idno type="wicri:Area/Ncbi/Curation">003C17</idno><idno type="wicri:Area/Ncbi/Checkpoint">003C17</idno><idno type="wicri:Area/Main/Merge">001984</idno><idno type="wicri:Area/Main/Curation">001988</idno><idno type="wicri:Area/Main/Exploration">001988</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Track: SCLC, Mesothelioma, Thymoma.</title><author><name sortKey="Scagliotti, Giorgio V" sort="Scagliotti, Giorgio V" uniqKey="Scagliotti G" first="Giorgio V" last="Scagliotti">Giorgio V. Scagliotti</name><affiliation><nlm:affiliation>Department of Oncology, University of Turin, Torino/ITALY.</nlm:affiliation><wicri:noCountry code="subField">Torino/ITALY</wicri:noCountry></affiliation></author><author><name sortKey="Gaafar, Rabab" sort="Gaafar, Rabab" uniqKey="Gaafar R" first="Rabab" last="Gaafar">Rabab Gaafar</name><affiliation><nlm:affiliation>National Cancer Institute, Cairo University, Cairo/EGYPT.</nlm:affiliation><wicri:noCountry code="subField">Cairo/EGYPT</wicri:noCountry></affiliation></author><author><name sortKey="Nowak, Anna" sort="Nowak, Anna" uniqKey="Nowak A" first="Anna" last="Nowak">Anna Nowak</name><affiliation><nlm:affiliation>School of Medicine And Pharmacology Qeii, Medical Centre Unit, University of Western Australia, Crawley/WA/AUSTRALIA.</nlm:affiliation><wicri:noCountry code="subField">Crawley/WA/AUSTRALIA</wicri:noCountry></affiliation></author><author><name sortKey="Vogelzang, Nicholas J" sort="Vogelzang, Nicholas J" uniqKey="Vogelzang N" first="Nicholas J" last="Vogelzang">Nicholas J. Vogelzang</name><affiliation><nlm:affiliation>US Oncology Comprehensive Cancer Centers of Nevada, Las Vegas/NV/UNITED STATES OF AMERICA.</nlm:affiliation><wicri:noCountry code="subField">Las Vegas/NV/UNITED STATES OF AMERICA</wicri:noCountry></affiliation></author><author><name sortKey="Von Wangenheim, Ute" sort="Von Wangenheim, Ute" uniqKey="Von Wangenheim U" first="Ute" last="Von Wangenheim">Ute Von Wangenheim</name><affiliation><nlm:affiliation>Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/GERMANY.</nlm:affiliation><wicri:noCountry code="subField">Biberach/GERMANY</wicri:noCountry></affiliation></author><author><name sortKey="Morsli, Nassim" sort="Morsli, Nassim" uniqKey="Morsli N" first="Nassim" last="Morsli">Nassim Morsli</name><affiliation><nlm:affiliation>Boehringer Ingelheim France S.A.S., Paris/FRANCE.</nlm:affiliation><wicri:noCountry code="subField">Paris/FRANCE</wicri:noCountry></affiliation></author><author><name sortKey="Velema, Derek" sort="Velema, Derek" uniqKey="Velema D" first="Derek" last="Velema">Derek Velema</name><affiliation><nlm:affiliation>Boehringer Ingelheim (Canada) Ltd./Ltée, Burlington/ON/CANADA.</nlm:affiliation><wicri:noCountry code="subField">Burlington/ON/CANADA</wicri:noCountry></affiliation></author><author><name sortKey="Popat, Sanjay" sort="Popat, Sanjay" uniqKey="Popat S" first="Sanjay" last="Popat">Sanjay Popat</name><affiliation><nlm:affiliation>Royal Marsden Hospital NHS Foundation Trust, London and Surrey/UNITED KINGDOM.</nlm:affiliation><wicri:noCountry code="subField">London and Surrey/UNITED KINGDOM</wicri:noCountry></affiliation></author></analytic><series><title level="j">Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</title><idno type="eISSN">1556-1380</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><affiliations><list></list><tree><noCountry><name sortKey="Gaafar, Rabab" sort="Gaafar, Rabab" uniqKey="Gaafar R" first="Rabab" last="Gaafar">Rabab Gaafar</name><name sortKey="Morsli, Nassim" sort="Morsli, Nassim" uniqKey="Morsli N" first="Nassim" last="Morsli">Nassim Morsli</name><name sortKey="Nowak, Anna" sort="Nowak, Anna" uniqKey="Nowak A" first="Anna" last="Nowak">Anna Nowak</name><name sortKey="Popat, Sanjay" sort="Popat, Sanjay" uniqKey="Popat S" first="Sanjay" last="Popat">Sanjay Popat</name><name sortKey="Scagliotti, Giorgio V" sort="Scagliotti, Giorgio V" uniqKey="Scagliotti G" first="Giorgio V" last="Scagliotti">Giorgio V. Scagliotti</name><name sortKey="Velema, Derek" sort="Velema, Derek" uniqKey="Velema D" first="Derek" last="Velema">Derek Velema</name><name sortKey="Vogelzang, Nicholas J" sort="Vogelzang, Nicholas J" uniqKey="Vogelzang N" first="Nicholas J" last="Vogelzang">Nicholas J. Vogelzang</name><name sortKey="Von Wangenheim, Ute" sort="Von Wangenheim, Ute" uniqKey="Von Wangenheim U" first="Ute" last="Von Wangenheim">Ute Von Wangenheim</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001988 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001988 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27676538
|texte= P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Track: SCLC, Mesothelioma, Thymoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27676538" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |